Impaired macrophage phagocytosis of bacteria in severe asthma

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Liang, Zhike ^a,b   Zhang, Qingling ^a,b   Thomas, Catherine M R ^a   Chana, Kirandeep K ^a   Gibeon, David ^a   Barnes, Peter J ^a   Chung, Kian F ^a   Bhavsar, Pankaj K ^a,c   Donnelly, Louise E ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Haemophilus influenzae; Macrophages; Phagocytosis; Staphylococcus aureus

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FORMOTEROL; POLYSTYRENE; PREDNISOLONE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FLUOROMETRY; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MIDDLE AGED; MONOCYTE; NEUTROPHIL COUNT; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PHAGOCYTOSIS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS;

EID: 84902938871     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-15-72     Document Type: Article

References (38)

1. Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, Burney P, Chanez P, Connett G, Corrigan C, de Blic J, Fabbri L, Holgate ST, Ind P, Joos G, Kerstjens H, Leuenberger P, Lofdahl C-G, McKenzie S, Magnussen H, Postman, Saetta D, Salmeron S, Silverman M, Sterk P. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 1999, 13:1198-1208.
2. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, Dweik RA, Fitzpatrick AM, Gaston B, Hew M, Hussain I, Jarjour NN, Israel E, Levy BD, Murphy JR, Peters SP, Teague WG, Meyers DA, Busse WW, Wenzel SE. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007, 119:405-413.
3. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K, Brasholt M, Heltberg A, Vissing NH, Thorsen SV, Stage M, Pipper CB. Childhood asthma after bacterial colonization of the airway in neonates. N Eng J Med 2007, 357:1487-1495.
4. Martin RJ, Kraft M, CHU HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001, 107:595-601.
5. Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010, 125:1178-1187.
6. Cazzola M, Matera MG, Blasi F. Macrolide and occult infection in asthma. Curr Opin Pulm Med 2004, 10:7-14.
7. Wood LG, Simpson JL, Hansbro PM, Gibson PG. Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic Res 2009, 44:146-154.
8. Zhang Q, Illing R, Hui C, Downey K, Carr D, Stearn M, Alshafi K, Menzies-Gow A, Zhong N, Fan Chung K. Bacteria in sputum of stable severe asthma and increased airway wall thickness. Respir Res 2012, 13:35.
9. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO. Disordered microbial communities in asthmatic airways. PLoS One 2010, 5:8578.
10. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011, 127:372-381.
11. Donnelly LE, Barnes PJ. Defective phagocytosis in airways diseasephagocytic dysfunction and airways disease. Chest 2012, 141:1055-1062.
12. Fitzpatrick AM, Holguin F, Teague WG, Brown LA. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 2008, 121:1372-1378.
13. Huynh ML, Malcolm KC, Kotaru C, Tilstra JA, Westcott JY, Fadok VA, Wenzel SE. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med 2005, 172:972-979.
14. Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006, 194:1375-1384.
15. Taylor AE, Finney-Hayward TK, Quint JK, Thomas CMR, Tudhope SJ, Wedzicha JA, Barnes PJ, Donnelly LE. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010, 35:1039-1047.
16. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003, 81:289-296.
17. Proceedings of the ATS Workshop on Refractory Asthma. Current Understanding, Recommendations, and Unanswered Questions. Am J Respir Crit Care Med 2000, 162:2341-2351.
18. Winkler AR, Nocka KH, Sulahian TH, Kobzik L, Williams CMM. In vitro modelling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function. Exp Lung Res 2008, 34:599-629.
19. Akagawa KS. Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int J Hematol 2002, 76(1):27-34.
20. Wood LG, Simpson JL, Hansbro PM, Gibson PG. Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic Res 2013, 44(2):146-154.
21. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lungmicrobiomein moderate and severechronic obstructive pulmonary disease. PLoS One 2012, 7(10):e47305.
22. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic Inflammation in Severe Persistent Asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
23. Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN, Hodge S, . AMAZES Study Research Group Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy 2013, 43:29-35. AMAZES Study Research Group.
24. Oliver BGG, Lim S, Wark P, Laza-Stanca V, King N, Black JL, Burgess JK, Roth M, Johnston SL. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 2008, 63:519-525.
25. Cazzola M, Matera MG, Rossi F. Bronchial hyperresponsiveness and bacterial respiratory infections. Clin Ther 1991, 13(1):157-171.
26. Gordon SB, Read RC. Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections. Br Med Bull 2002, 61:45-61.
27. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008, 63:784-790.
28. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, Adcock I, Fan Chung K, . National Heart Lung and Blood Institute's Severe Asthma Research Program Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174:134-141. National Heart Lung and Blood Institute's Severe Asthma Research Program.
29. Oczypok EA, Oury TD, Chu CT. It's a cell-eat-cell world: autophagy and phagocytosis. Am J Pathol 2013, 182:612-622.
30. Manni ML, Tomai LP, Norris CA, Thomas LM, Kelley EE, Salter RD, Crapo JD, Chang LY, Watkins SC, Piganelli JD, Oury TD. Extracellular superoxide dismutase in macrophages augments bacterial killing by promoting phagocytosis. Am J Pathol 2011, 178:2752-2759.
31. Wu W, Samoszuk MK, Comhair SAA, Thomassen MJ, Farver CF, Dweik RA, Kavuru MS, Erzurum SC, Hazen SL. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000, 105:1455-1463.
32. Thimmulappa RK, Gang X, Kim JH, Sussan TE, Witztum JL, Biswal S. Oxidized phospholipids impair pulmonary antibacterial defenses: Evidence in mice exposed to cigarette smoke. Biochem Biophys Res Commun 2012, 426:253-259.
33. Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with â-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009, 65(9):853-871.
34. Chung KF, Marwick JA. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci 2010, 1203:85-91.
35. Marwick JA, Caramori G, Casolari P, Mazzoni F, Kirkham PA, Adcock IM, Chung KF, Papi A. A role for phosphoinositol 3-kinase [delta] in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 2010, 125:1146-1153.
36. Zetterlund A, Larsson PH, Müller-Suur C, Palmberg L, Larsson K. Budesonide but not terbutaline decreases phagocytosis in alveolar macrophages. Respir Med 1998, 92:162-166.
37. Nino DF, Cauvi DM, De Maio A. A commonly used antifungal, inhibits fcã receptor-mediated phagocytosis: alteration of fcγ receptor glycosylation and gene expression. Shock 2014, 42(1):52-59.
38. Gao X, Ray R, Xiao Y, Ishida K, Ray P. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm Pharmacol Ther 2010, 23:97-106.